FabRx Ltd., a pioneer in 3D printing of pharmaceuticals that is actually a spin-off from University College London (UCL), has released the first pharmaceutical 3D printer M3DIMAKER™ for the manufacture of personalised medicines. The novel system has been rigorously tested in hospitals, pharmacies and research institutes around the world.
FabRx performs World’s First Clinical Study to Bring Personalised Patient Treatment by 3D Printing of Pharmaceuticals
2 Mins read
FabRx, a leader in 3D printing of pharmaceuticals, has successfully accomplished the world’s first in-human clinical study using their proprietary Printlets™ technology. This…